Patient Rating:

4.8 out of 5

81 Patient Ratings
25 Patient Comments

Kenneth F. Grossmann, M.D., Ph.D.

Specialties

Languages

  • English

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 585-0206 Huntsman Cancer Institute
Clinic 2D, Melanoma
2000 Circle of Hope
Salt Lake City, UT 84112
Map

Bio

Kenneth Grossmann, MD, PhD

Assistant Professor, Division of Oncology, Department of Medicine

Kenneth Grossmann, MD, PhD, is an assistant professor in the Division of Oncology for the Department of Medicine and a Huntsman Cancer Institute investigator. He is a medical oncologist with the Melanoma and Cutaneous Oncology Program.

Grossmann sees patients with advanced melanoma and also conducts clinical trials. His laboratory research focuses on a demethylase enzyme complex that can cause the hallmarks of many kinds of cancer, including melanoma. Additionally, he focuses on understanding other signaling pathways in melanoma tumors and developing methods to overcome resistance to targeted therapies. Better understanding of melanoma tumor biology may lead to new ways to treat the disease.

Grossman completed undergraduate studies in biology at Whitman College in Walla Walla, Washington. He earned his PhD and MD degrees from the Department of Molecular and Medical Genetics at Oregon Health & Sciences University (OHSU) in Portland. He completed a combined fellowship in medical oncology at OHSU and the University of Utah, and also participated in a melanoma and cutaneous oncology rotation at MD Anderson Cancer Center.

Board Certification and Academic Information

Academic Departments Internal Medicine - Assistant Professor
Academic Divisions Oncology
Board Certification American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Medical Oncology)
National Board of Medical Examiners
Cancer Center Programs Experimental Therapeutics

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.9
My confidence in care provider
4.9
Time care provider spent with me
4.8
Care provider spoke using clear language
4.8
Care provider's effort to include me in decisions
4.8
Care provider's concern for questions & worries
4.8
Care provider's explanation of condition/problem
4.7
Wait time at clinic
4.3
Care provider's friendliness and courtesy
4.8

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

June 26, 2014

Theseguys r the best

June 07, 2014

Every one seems to care and no one speaks above our heads, nor do they treat us as if we can't understand. Everything is explained well and we always feel welcome to ask about any thing.

May 14, 2014

DR.GROSMAN IS AN OUTSTANDING CARE GIVER WITH AN ENORMOUSLY ATTENTIVE MANNER.

April 05, 2014

Dr Grossman is so good in how he talks about the cancer, he brings peace and hope into my soul, the cancer will probably not go away, but this team is very comforting

March 06, 2014

I tell everyone I talk with, to go to Huntsman first, if cancer is a concern.

January 12, 2014

Excellent

August 12, 2013

good

June 04, 2013

Dr. Grossmann and his staff are amazing. Thank you to all of you for making my mom's visits something she actually looks forward to.

May 20, 2013

best ever!!

November 26, 2012

These guys are the best!

November 19, 2012

This was a consultation, so no treatment plan was made.

November 06, 2012

I am at the best cancer hospital I can be at and getting care from a team of Doctors that are the best!

November 05, 2012

Dr. Grossmann and his staff are very kind and good to get explanations and next steps. I really like them and think I'm getting the best care for my situation.

October 29, 2012

I can't even begin to describe how much I appreciate Dr. Grossman's attentive care.

September 14, 2012

Dr. Grossmann and his staff are wonderful, caring people. I appreciate all that they do for us.

April 26, 2012

I highly recommend the Huntsman Center.

April 26, 2012

Dr. Kenneth Grossman is a great doctor and I am fortunate to have him on my team, working to solve my health issues. Also, I'd like to mention the great care and effort I feel from my other main two contacts at Huntsman, Karen O'Driscoll and Caroyn Luckett.

April 25, 2012

Can't ask for better care anywhere.

March 28, 2012

I understand the tremendous about of time individual care takes. I have never felt rushed, I was always made to feel my personal worth and health was their primary concern.

March 05, 2012

don't remember

March 01, 2012

Again, I am so glad I started treatment at Huntsman and have been totally pleased with my care.

February 08, 2012

I know without this institute, the research done and the professionalism in every area showen by the doctors and staff, I wouldn't be here today. Circle of hope was the correct address, because the entire staff gives not only hope, but a reason to fight.

February 02, 2012

Dr. Grossman and his staff are A1 and we feel very comfortable with all of them.

January 05, 2012

received excellent news about my prognosis,and all careproviders were encouraging

January 04, 2012

I'm amazed at Dr Grossmann's knowledge. He is an expert with his field andothers. He follows up with any referrals. I trust him.

Academic Profile

Board Certification and Academic Information

Academic Departments Internal Medicine - Assistant Professor
Academic Divisions Oncology
Board Certification American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Medical Oncology)
National Board of Medical Examiners
Cancer Center Programs Experimental Therapeutics

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 585-0255 Huntsman Cancer Institute
Oncology
2000 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

Dr. Grossmann received his medical and doctorate degrees from the Oregon Health Sciences University (OHSU) in Portland Oregon. He completed his residency training in internal medicine at OHSU. As a resident, Dr. Grossmann was awarded the John S. Miller Teaching Award by the graduating medical students in 2005– an award given to the most gifted educator among all interns. During his subspecialty training in medical oncology, Dr. Grossmann completed clinical and research work at OHSU, the University of Utah, and the MD Anderson Cancer Center in Houston Texas where he focused his training on the clinical care of Stage III and IV melanoma patients. In 2009 Dr. Grossmann joined the University of Utah faculty in the Department of Medical Oncology, and advanced to the rank of Assistant Professor in 2011. He is an investigator in the Huntsman Cancer Institute and a member of the Experimental Therapeutics program. Dr. Grossmann is a physician-scientist whose research focus is on understanding the mechanisms of drug resistance, and radiation resistance of melanoma and other cancers. He has published in peer reviewed journals such as Cell, Mutation Research, Diagnostic Cytopathology, and Journal of Translational Medicine. Dr. Grossmann is recognized regionally, nationally, and internationally as a melanoma expert, and as such has been an invited speaker at the Society of Utah Medical Oncology, and at the Future Perspectives in Melanoma Research Meeting in Naples Italy in 2011. He is an active member of the Southwest Oncology Group where he focuses on the design and execution of clinical trials to define the standard of care in melanoma medical oncology. In addition to his work on melanoma, Dr. Grossmann also sees patients with non-melanomatous tumors such as basal cell carcinoma, squamous cell carcinoma of the skin, and cancers of the head and neck. He serves on the National Comprehensive Cancer Network (NCCN) panel for non-melanomatous skin tumors which defines national standards for the oncologic care of these tumor types.

Education

Education History

Type School Degree
Fellowship University of Utah School of Medicine
Medical Oncology
Fellow
Fellowship Oregon Health Sciences University
Medical Oncology
Fellow
Residency Oregon Health Sciences University
Internal Medicine
Resident
Internship Oregon Health Sciences University
Internal Medicine
Intern
Professional Medical Oregon Health Sciences University
Medicine
M.D.
Doctoral Training Oregon Health Sciences University
Molecular and Medical Genetics
Ph.D.
Undergraduate Whitman College
Biology
B.A.

Publications

Selected Provider Publications

Journal Article

  1. Andtbacka RH, Donaldson MR, Bowles TL, Bowen GM, Grossmann K, Khong H, Grossman D, Anker C, Florell SR, Bowen A, Duffy KL, Leachman SA, Noyes RD (2013). Sentinel lymph node biopsy for melanoma in pregnant women. Ann Surg Oncol, 20(2), 689-96.
  2. Ascierto PA, Grimaldi AM, Curti B, Faries MB, Ferrone S, Flaherty K, Fox BA, Gajewski TF, Gershenwald JE, Gogas H, Grossmann K, Hauschild A, Hodi FS, Kefford R, Kirkwood JM, Leachmann S, Maio M, Marais R, Palmieri G, Morton DL, Ribas A, Stroncek DF, Stewart R, Wang E, Mozzillo N, Marincola FM (2012). Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011". J Transl Med, 10, 83.
  3. Grossmann KF, Colman H, Akerley WA, Glantz M, Matsuoko Y, Beelen AP, Yu M, De Groot JF, Aiken RD, Olson JJ, Evans BA, Jensen RL (2012). Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. J Neurooncol, 110(2), 257-64.
  4. Rai K, Sarkar S, Broadbent TJ, Voas M, Grossmann KF, Nadauld LD, Dehghanizadeh S, Hagos FT, Li Y, Toth RK, Chidester S, Bahr TM, Johnson WE, Sklow B, Burt R, Cairns BR, Jones DA (2010). DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC. Cell, 142(6), 930-42.
  5. Grossmann KF, Ward AM, Matkovic ME, Folias AE, Moses RE (2001). S. cerevisiae has three pathways for DNA interstrand crosslink repair. Mutat Res, 487(3-4), 73-83.
  6. Grossmann KF, Ward AM, Moses RE (2000). Saccharomyces cerevisiae lacking Snm1, Rev3 or Rad51 have a normal S-phase but arrest permanently in G2 after cisplatin treatment. Mutat Res, 461(1), 1-13.
  7. Grossmann KF, Brown JC, Moses RE (1999). Cisplatin DNA cross-links do not inhibit S-phase and cause only a G2/M arrest in Saccharomyces cerevisiae. Mutat Res, 434(1), 29-39.

Review

  1. Grossmann AH, Grossmann KF, Wallander ML (2012). Molecular testing in malignant melanoma. [Review]. Diagn Cytopathol, 40(6), 503-10.

Book

  1. Grossmann KF (2000). DNA repair and cell cycle checkpoints in response to DNA crosslinking agents in S. cerevisiae. PhD Dissertation. Oregon Health Sciences University Library.
  2. Grossmann KF (1994). Genomic imprinting in Drosophila Melanogaster. Undergraduate Senior Thesis. Walla Walla, WA: Whitman College.

Abstract

  1. Jimeno A, Posner M, Weiss J, Wirth L, Saba N, Cohen RB, Popa E, Argiris A, Grossmann KF, Sukari A, Korth C, Wilson D, McClure T, Alimzhanov M, Pearsall S, Attie KM, Sherman ML, Pandya SS (June 2014). Phase 2 Study of Dalantercept Monotherapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Abstract]. Poster Presentation ASCO Annual Meeting (May 30 - June 03, 2014).
  2. Chmielowski B, Hamid O, Minor DR, DAngelo SP, Pennock GK, Grossmann KF, Ascierto PA, Daud A, Dummer R, Hodi FS, Lebb S, Robert C, Sosman JA, Yang A, Lambert A, Weber JS (2013). A phase 3 open-label study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) vs investigator’s choice in advanced melanoma patients progressing post anti-CTLA-4 therapy. Abstract #112577. Poster Presentation ASCO Annual Meeting (May 31 - June 4, 2013) [Abstract].
  3. Grossmann KF, Infante JR, LoRusso PM, Sharma S, Blackman SC, Carson SW, Krachey EC, Nebot N, Ouellet D, Gordon MS (2012). Effects of a high-fat meal on the pharmacokinetics of orally administered GSK2118436 in patients with BRAF mutation-positive tumors. Abstract Number 3766. Poster Presentation AACR Annual Meeting 4/4/2012 Chicago IL [Abstract]. Cancer Research, 72:3766, doi:10.1158/153.
  4. Grossmann KF, Ward JH, Akerley WL, Glantz MJ, De Groot JF, Aiken R, Olson JJ, Matsuoka Y, Yu MK, Jensen RL (2010). A clinical study investigating MPC-6827 with carboplatin in the treatment of patients with relapsed glioblastoma multiforme.Poster presentation ASCO Annual Meeting 6/5/2010 [Abstract]. J Clin Oncol 28:15s, 2010 (suppl; abstr 2095), 28, 2095.
  5. Grossmann KF, Ward AM, Moses RE (2000). Mutants in two DNA polymerases, REV3 and RAD30 differ in cross-link repair [Abstract]. Am J Hum Genet.
  6. Grossmann KF, Bruun DA, Brown JC, Moses RE (1998). The human SNM1 orthologue does not correct a yeast snm1mutant [Abstract]. Am J Hum Genet, 63(4), 2102.
  7. Grossmann KF, Hejna JA, Moses RE (1996). The Fanconi Anemia Group C Gene Shares a Conserved Domain with MEC1 [Abstract]. Am J Hum Genet, 59(4), 2138.

Report

  1. Terakedis BE, Anker CJ, Bowen GM, Andtbacka RHI, Sause WT, Grossmann KF, BowlesTL, Leachman SA, Noyes RD, Hitchcock YJ, Shrieve DC (Pending). Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.

Poster

  1. Grossmann KF, Ward AM, Moses RE (2000). Cisplatin DNA damage and the cell cycle in S. cerevisiae. Poster session presented at Fifth Cold Spring Harbor Meeting on The Cell Cycle.
  2. Grossmann KF, Ward AM, Matkovic ME, Moses RE (1999). Cisplatin DNA cross-links: cell cycle arrest and repair in S. cerevisiae. Poster session presented at American Society of Microbiology, DNA Repair and Mutageneisis meeting.
  3. Grossmann KF, Ward AM, Moses RE (1999). DNA Repair and Cell Cycle Checkpoints in Response to Crosslinks in Fanconi Anemia and S. cerevisiae. Poster session presented at American Society of Microbiology, yeast Genetics and Human Disease II.
  4. Grossmann KF, Ward AM, Matkovic ME, Moses RE (1999). The effects of DNA crosslinks on cell cycle progression in S. cerevisiae. Poster session presented at Eleventh Annual International Fanconi Anemia Scientific Symposium.
  5. Grossmann KF (1998). Cell Cycle Checkpoints and Crosslink Repair in the Yeast S. cerevisiae. Poster session presented at Oregon Health Sciences University, Student Research Forum.
  6. Grossmann KF, Bruun DA, Brown JC, Moses RE (1998). SNM1, a yeast mutant specifically sensitive to DNA crosslinks, is not corrected by overexpression of the human SNM1 cDNA. Poster session presented at Tenth Annual International Fanconi Anemia Scientific Symposium.
  7. Grossmann KF (1997). The effects of Cisplatin on Gene Expression and the Cell Cycle Checkpoints of Saccharomyces cerevisiae. Poster session presented at Oregon Health Sciences University Student Research Forum.

Clinical Trials

Video & News

News

Video